Ameritas Investment Partners’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.2K | Hold |
3,449
| – | – | ﹤0.01% | 1980 |
|
|
2025
Q1 | $67.9K | Hold |
3,449
| – | – | ﹤0.01% | 1934 |
|
|
2024
Q4 | $77.6K | Hold |
3,449
| – | – | ﹤0.01% | 1932 |
|
|
2024
Q3 | $88.1K | Hold |
3,449
| – | – | ﹤0.01% | 1872 |
|
|
2024
Q2 | $80.6K | Buy |
3,449
+1,521
| +79% | +$35.5K | ﹤0.01% | 1857 |
|
|
2024
Q1 | $33.9K | Hold |
1,928
| – | – | ﹤0.01% | 2337 |
|
|
2023
Q4 | $26.7K | Hold |
1,928
| – | – | ﹤0.01% | 2455 |
|
|
2023
Q3 | $26.3K | Hold |
1,928
| – | – | ﹤0.01% | 2418 |
|
|
2023
Q2 | $39.4K | Buy |
+1,928
| New | +$39.4K | ﹤0.01% | 2190 |
|
|
2021
Q2 | – | Sell |
-109
| Closed | -$4K | – | 3104 |
|
|
2021
Q1 | $4K | Hold |
109
| – | – | ﹤0.01% | 3026 |
|
|
2020
Q4 | $10K | Hold |
109
| – | – | ﹤0.01% | 2774 |
|
|
2020
Q3 | $9K | Hold |
109
| – | – | ﹤0.01% | 2758 |
|
|
2020
Q2 | $12K | Buy |
+109
| New | +$12K | ﹤0.01% | 2622 |
|